Frequently Asked Questions

Nouri is an independent publisher. We build free dose calculators, write cost guides, and maintain a side-by-side comparison of licensed companies that prescribe GLP-1 medication. Nouri is not a telehealth service: it does not prescribe, dispense or sell medication, does not arrange prescriptions, and is not accepting patients. Some links in the comparison earn Nouri a commission, and we say so on the page where those links appear rather than only in the footer.

No one, as a patient: Nouri’s telehealth program has closed and Nouri is not accepting patients. The calculators, guides and comparison on this site are free to use, with no account to open. Who qualifies for a GLP-1 medication is decided by the licensed clinician who evaluates you.

There is nothing to begin with Nouri: Nouri’s telehealth program has closed and Nouri is not accepting patients. To start GLP-1 treatment, you would go to a licensed telehealth company or your own clinician. Our comparison lists licensed companies with their own published prices and the date we checked them.

It doesn’t: Nouri’s telehealth program has closed and Nouri is not accepting patients. How quickly a licensed company reviews an intake and ships medication varies by company and state; check on its own site.

Nouri ships nothing: it does not prescribe, dispense or sell medication. What a shipment contains, such as dosing instructions and supplies, is set by the company and pharmacy that fill your prescription.

Nothing now: The Program has closed. What Nouri publishes is free: dose calculators, cost guides and a comparison of licensed companies. What each company includes in its own price differs, and is stated on its entry in the comparison.

That is a decision for you and the licensed clinician who evaluates you. Semaglutide is a single-action GLP-1 therapy; tirzepatide is a dual-action therapy that engages two metabolic pathways. Compounded formulations of these medications have not been evaluated in randomized controlled trials.

Semaglutide and tirzepatide for weight management are usually once-weekly subcutaneous injections. The prescribing clinician explains dosing, and the dispensing pharmacy includes instructions with the medication.

The Program has closed. How long to stay on a GLP-1 medication is a decision for you and the clinician who prescribes it.

The Program has closed. If a GLP-1 medication isn’t working for you, raise it with the clinician who prescribes it; dose and treatment decisions belong to them.

Semaglutide and tirzepatide belong to a class of medications called GLP-1 receptor agonists. They work by mimicking GLP-1, a hormone the body releases after eating that helps regulate appetite and blood sugar. GLP-1 receptor agonists act on appetite-control centers in the brain, slow how quickly the stomach empties, and support insulin regulation, which together can reduce hunger and food intake (peer-reviewed literature, U.S. National Library of Medicine). Tirzepatide additionally activates a second gut-hormone receptor (GIP). GLP-1 medications carry risks and contraindications — review the Important Safety Information before considering treatment. Compounded semaglutide and tirzepatide are not FDA-approved; whether treatment is appropriate is a decision made by a U.S.-licensed physician based on your individual health profile.

FDA-approved semaglutide and tirzepatide products are commercially manufactured under FDA oversight for safety, effectiveness, and manufacturing quality. Compounded semaglutide and tirzepatide are prepared by a state-licensed compounding pharmacy for an individual patient based on a prescription, and are not FDA-approved — the FDA does not verify the safety, effectiveness, or quality of compounded drugs. The FDA has described concerns about compounded GLP-1 products, including dosing errors and fraudulent or mislabeled products.

Nouri has no providers and no pharmacy. It does not practice medicine, prescribe, or dispense: it is an independent editorial site. Each company in our comparison uses its own licensed clinicians and its own pharmacy, and a company that will not name the pharmacy that dispenses its medication is not listed.

Yes. Pharmacy compounding is a long-standing, lawful practice regulated under federal and state law. Compounded medications are prepared by state-licensed pharmacies pursuant to a valid prescription from a licensed provider for a specific patient. Compounded drugs are not FDA-approved and the FDA does not verify their safety, effectiveness, or quality. A compounded prescription is appropriate only when a licensed physician documents a specific clinical need for an individual patient.

The Program has closed, and Nouri charges nothing. Everything we publish is free and there is no account to open. What licensed companies charge varies and changes often; our comparison on the weight loss page lists each company’s own published cash price with the date we read it from their site. Compounded therapies are not FDA-approved.

Nouri sells nothing, so there is nothing to cover. Compounded GLP-1 medications are rarely covered by insurance, and coverage of brand-name GLP-1s for weight loss varies by plan. Some purchases may be eligible for HSA or FSA reimbursement; check with your plan administrator.

Nouri sells nothing to discount. Many licensed companies charge less per month on longer prepaid plans; before committing, compare the all-in cost and what happens to the unused balance if you stop.

Nouri ships nothing. How often medication ships on a prepaid plan is set by each company; check it before you choose a plan length.

Yes. The most common side effects include nausea, fatigue, diarrhea, and constipation, which typically improve as your body adjusts. Important: GLP-1 medications carry a warning for a rare but serious risk of thyroid C-cell tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See the Important Safety Information page for the complete list of side effects, serious warnings, and contraindications, and discuss these risks with the clinician who evaluates you.

Nouri has no results to report, because Nouri no longer treats anyone. The trial figures for the branded molecules — a mean of about 14.9% body-weight reduction on semaglutide 2.4 mg over 68 weeks, and about 20.9% on tirzepatide 15 mg over 72 weeks — are set out on our weight loss page with both trials cited. Those trials ran alongside diet and exercise, no compounded product has been tested in them, and individual results vary.

Nouri no longer provides nutrition or movement plans. In the trials of the branded GLP-1 medications, the drug was used alongside diet and exercise; ask the clinician who prescribes for you what fits your situation.

The Program has closed, so there is nothing to stop with Nouri. If you are thinking about stopping a GLP-1 medication, discuss how to do it with the clinician who prescribes it.

None. Nouri does not dispense medication and has no pharmacy. Each company in our comparison uses its own, and a company that will not name the pharmacy that dispenses its medication is excluded from the comparison entirely — that is one of five published criteria, applied before any commercial conversation. The criteria are set out in full on our editorial policy page.

Nouri does not ship anything. Availability by state is set by each company and changes; some require a video visit before a prescription can be written in certain states. Check on the company's own site before committing to a plan length, because a prepaid twelve-month rate is worth much less if the company cannot serve you where you live.

Nouri has no clinicians and provides no care. Our health pages are written by the Nouri Editorial Team and medically reviewed by Amber Patel, MD, who reviews the accuracy of what we publish and does not treat readers. Every health page carries the reviewer's name and the date it was last reviewed. Clinical decisions are made by the licensed clinician who has evaluated you.

No. Compounded therapies are not FDA-approved. They are prepared by state-licensed pharmacies based on a valid prescription from a licensed physician.

There is nothing to cancel with Nouri: it sells no plans or subscriptions, and its former telehealth program has closed. Cancellation and refund terms for a GLP-1 plan are set by the company you sign up with; read them before you pay.

Nouri has no physicians and no patient portal. Contact your clinician through the company that prescribed for you. Former patients with a question can write to care@joinnouri.com.

Nouri no longer has patient accounts, an intake questionnaire or a patient portal, and does not ask for your medical history. How this site handles analytics and other data is described in our Privacy Policy.

No. Nouri does not prescribe, dispense or sell medication, and is not accepting patients. It publishes calculators, cost guides, and a comparison of licensed companies. Prescribing decisions are made by licensed clinicians who have evaluated the individual patient.